These results suggest that instead of activating novel signaling pathways, FLT3 utilizes components of BCR signaling pathway to promote proliferation and survival of lymphoid cells in B cells acute lymphoblastic leukemia. Here, FLT3 is linked to acute lymphoblastic leukemia.